等待開盤 12-27 09:30:00 美东时间
-0.190
-0.72%
今日重点评级关注:富国银行:维持Milestone Pharmaceuticals"超配"评级,目标价从4美元升至8美元;富国银行:维持Kyverna Therapeutics"超配"评级,目标价从31美元升至33美元
12-17 10:46
JP Morgan analyst Anthony Elian maintains First Hawaiian (NASDAQ:FHB) with a Underweight and raises the price target from $27 to $29.
12-16 23:47
今日重点评级关注:Piper Sandler:维持MeiraGTx Hldgs"超配"评级,目标价从28美元升至30美元;RBC Capital:维持4D Molecular Therapeutics"跑赢大市"评级,目标价从26美元升至32美元
11-12 11:43
Barclays analyst Jared Shaw upgrades First Hawaiian (NASDAQ:FHB) from Underweight to Equal-Weight and raises the price target from $26 to $28.
11-11 21:38
今日重点评级关注:HC Wainwright & Co.:维持PepGen"买入"评级,目标价从12美元升至18美元;Piper Sandler:维持Prothena Corp"超配"评级,目标价从15美元升至36美元
10-29 09:25
今日重点评级关注:Guggenheim:上调Neumora Therapeutics评级至"买入",目标价14美元;韦德布什:上调Fate Therapeutics评级至"跑赢大市",目标价从5美元升至7美元
10-28 10:08
Piper Sandler analyst Matthew Clark maintains First Hawaiian (NASDAQ:FHB) with a Neutral and raises the price target from $27 to $28.
10-27 21:18
First Hawaiian (NASDAQ:FHB) declared $0.26/share quarterly dividend, in line with previous. Forward yield 4.39% Payable Nov. 28; for shareholders of record Nov. 17; ex-div Nov. 17. See FHB Dividend Sc...
10-24 20:04
First Hawaiian (NASDAQ:FHB) reported quarterly earnings of $0.59 per share which beat the analyst consensus estimate of $0.52 by 13.03 percent. This is a 22.92 percent increase over earnings of $0.48 per share from the
10-24 20:02
Companies Reporting Before The Bell • Eni (NYSE:E) is expected to report quarte...
10-24 16:32